Many, LANCT07039396Now EnrollingIRB Ready

Diabetic Foot Ulcer Clinical Trial in Many, LA

Access cutting-edge diabetic foot ulcer treatment through this clinical trial at a research site in Many. Study-provided care at no cost to qualified participants.

Sponsored by NuScience Medical Biologics, LLC

Quick Self-Assessment

See if you qualify for this Many location

Preparing your pre-screening questions…

Expert Care in Many

Access diabetic foot ulcer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related diabetic foot ulcer treatment provided free

Apply for This Many Location

Check if you qualify for this diabetic foot ulcer clinical trial in Many, LA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Many

    Convenient for LA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Many site if eligible
  4. 4Begin participation

About This Diabetic Foot Ulcer Study in Many

This is a prospective case series evaluating the efficacy and safety of NeoThelium FT Amnion Skin Graft in the Mangement of Diabetic Foot Ulcers

Sponsor: NuScience Medical Biologics, LLC

Who Can Participate

Inclusion Criteria

Male or Female, 18 years of age or older
Subject has a medical diagnosis of Type I or Type II Diabetes Mellitus requiring oral or glycemic control and/or insulin replacement therapy with a diabetic foot ulcer
Subject has a diabetic foot ulcer of Wagner grade 1, 2, or 3 without infection or clinically visible exposed bone. Wagner 3 is acceptable if the diagnosis is acute osteomyelitis and the subject has successfully completed IV antibiotic treatment prior to screening.
Ulcer area is a minimum of 0.5 cm2 and a maximum of 25 cm2 at first treatment visit
Subject is able and willing to follow the protocol requirements
Subject had signed informed consent
Adequate circulation if wound is location on the lower extremity demonstrated by an ABI of \>0.7 and \<1.3, or TBI of \>0.6 within 30 days prior to informed consent OR an arterial ultrasound noted with patent circulation and without significant stenosis 90 days prior to the first treatment visit.
Diabetic foot ulcer is being treated with TCC offloading therapy OR Fixed Ankle Walker if approved by Medical Monitor for 7 days prior to treatment visit 1
Wound free of clinical infection (no purulent discharge, cellulitis, or osteomyelitis) post-debridement.
Record of serum hemoglobin A1c within 90 days prior to the first treatment visit

Exclusion Criteria

Subject is unable to comply with protocol treatment
Target ulcer is a Wagner 3 of acute osteomyelitis that has not been successfully treated with 6 weeks of IV antibiotics or is diagnosed as chronic refractory osteomyelitis.
Wagner 3, 4, or 5 involving tendon, bone, or joint.
Presence of systemic infection, sepsis, or osteomyelitis at screening.
Multiple DFUs on the same foot with \< 2 cm separation from the target ulcer.
Subject has major uncontrolled medical disorders in the opinion of the investigator, such as serious cardiovascular, renal, liver, pulmonary, autoimmune, palliative care, or inherited blood disorders that may affect wound healing.
Subject actively being treated for malignant disease or history of malignancy or radiation therapy at the site of wound.
Subject has comorbid conditions that may compromise subject safety in the opinion of the investigator
Known contraindications or hypersensitivity to amniotic membrane products or components of NeoThelium FT.
Concurrent participation in alternative clinical trial that involves investigational drug or HCT/P interfering with wound treatment and/or healing.
Subject is pregnant or breastfeeding
Subject with history of immunosuppressant treatment (systemic corticosteroids \>10mg daily dose), cytotoxic chemotherapy, or topical steroid application to the ulcer surface for \>2 weeks duration within 30 days prior to the first treatment visit; or anticipated use of the above during the course of the study
Wound previously treated with CAMPs, tissue engineered, or scaffold materials within 30 days prior to enrollment
Index ulcer suspicious of neoplasm in the opinion of the principal investigator

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Many?

Yes, this clinical trial (NCT07039396) has an active research site in Many, LA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Diabetic Foot Ulcer Treatment Options in Many, LA

If you're searching for diabetic foot ulcer treatment options in Many, LA, this clinical trial (NCT07039396) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Many research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetic foot ulcer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all diabetic foot ulcer clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Many, LA

See all essential tremor clinical trials recruiting in Many — not just this study.

Browse Essential Tremor Trials in Many →

Browse More Trials by Condition

Essential Tremor TrialsType 2 Diabetes TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Many?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Many, LA